José Siles GonzálezEsteban Sáez-GonzálezJosé M González-NavajasPedro ZapaterJuan J Pérez SantonjaMaría PlanellesPascual MarcoMariano AndrésEnriqué de-MadariaElena SanmartínP Más-SerranoHéctor PinargoteAntonio PicóCristóbal RichartLaura SempereDiego TorrúsJenny de la Torre-AbokiJesús María Aranaz AndrésJMRamosrJUSTO SERRANO-VICENTEP VelaPascual Fernandez-AbellanJuan QuilesMás Martínez JJJ R AparicioJ González de DiosJuan Pablo Caballero RomeuPablo González-LópezL Sánchez-TejadaJ De Capadocia RosellCelia VillodrePurificación González-DelgadoPedro Álvarez-ChinchillaCarolina Mangas-SanjuanCristina Villalba-RiquelmeRodrigo Jover
P108
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusExpanded Access Program for Maraviroc At Multiple CentersStudy of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve SubjectsLopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With LipoatrophyPatient-reported Outcome Scale in Acute PancreatitisA Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Subjects With Manifestations of Plaque Psoriasis and Impaired Quality of Life.Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 ConnectorTRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisA Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung CancerTreatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 YearsStudy to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in SpainRanolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisRIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With CandidemiaEvaluation of Nutritional Practices in the Critical CareComparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile InfectionSafety Profile of Idelalisib in Patients With Refractory Follicular LymphomaA Study of MTIG7192A in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerLeft Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on HemodialysisA Phase 3, Randomized, Controlled Study of Prophylactic and On-demand Treatment of cTTP With BAX 930 (rADAMTS13)Long-Term Follow-up StudyEdoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsHealth-related Quality of Life in Patients on AnticoagulantsStudy to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisSecondary Prevention of Cardiovascular Disease in the Elderly Trial
P6153
Q17635616-8D6B7AC2-803C-4FC2-B8E6-83D02033499AQ39190214-CE1678D6-B4C2-4904-90D6-23EB69900F8BQ39836999-F0473BFA-EEED-4330-B40D-E0AEE3F555B0Q39837042-EA490392-E940-49C4-B25F-3724184268A4Q41622964-37223711-3AD2-4C53-97FF-C209C0988753Q42479683-0E934288-5CB7-4997-BF13-046ACC31B7F4Q45879272-EEDD28EB-A4AC-4602-B923-1B0E021E3762Q48357995-3F7554DE-D0F1-458C-BB38-35D2DDF48B22Q53333516-BEE05218-B1F3-4E17-9397-F961D8E73364Q54391806-272131C1-4DC7-4DD5-9B72-878F95BF3CE4Q55873714-67558D4E-EFE1-49F1-8A83-C79C2612E98AQ56589930-75A8B13C-D1F8-4EFE-8636-70169DEE1E49Q58049971-89D23A89-B059-420C-A3F3-4AD58E5223CFQ59666532-6F6F505F-AADE-4D1D-B34E-48CACD2DA96DQ60316164-BD97251C-E095-4D6A-A29D-858809AB4554Q61988692-05D1B4E8-15AF-42A7-B4E9-4D319171DE98Q61988692-9EEDF0BA-12AC-40FB-AD0C-FFF321DCE528Q61988692-B38EBC8D-8DEF-4123-9F0E-420C070DAF72Q64007549-11B05384-A189-46F7-A1F8-76D4C8F226D2Q64007549-6BAAB894-D37D-498B-B324-D53DD95AC61CQ64732121-599EA50C-12A6-4580-9809-483A7D09B0B9Q64732476-D85A2594-CB2C-4ED7-A5F1-26D85FE2DE85Q64863651-14CE656C-EF06-4ABC-AC4D-E0F059668A72Q67857743-2E648317-0605-4A11-9C2D-7BB4BA5FECBFQ67857743-6DBA0EEE-BFA7-4857-ABED-47922ABCF0F9Q73062595-A4B5E9E1-C235-4699-BBB1-50C6D72C3960Q73727657-42389617-8926-461C-9B25-FC836DE84A29Q77224141-76CC9AE7-155B-4FA0-BB7C-851B172C6E92Q78147863-D3D655BE-906A-4B68-9642-0A17BB5D761DQ79913802-FD635C6B-B98D-4A52-825E-9B42D4F04626Q81232603-1E2F25F4-48E2-4CC3-83C0-604AB690E1AEQ81232603-E8F8D111-7D2B-48E2-9EDA-BB5740A83864Q82224975-D89354D9-0B84-4447-AFF6-826CFBEA1054Q83756001-0C45B5EE-4FD2-4DCF-B1DF-B428F9B35101Q83756001-4D5F0BD2-3243-4B5A-869E-973F6AD47292Q83756001-9B6CA28F-19FE-4824-BB4B-942B89EDF8DBQ84294961-8926218E-49F8-4367-8E3B-59FBB511C60BQ84885693-DDBEC820-C541-4AE7-B14D-48FBFE63C22DQ88716340-4890D6C8-8E3B-45C7-B3BE-2EA49238ABC3Q88767282-0CC5275F-67FF-4066-83F2-85FBBD3FDCAE
P108
Q61917509-EBBCC6B4-6791-468C-9114-54FBD96AE095Q61921417-ECA1AF0D-4B76-4DF8-9F69-1221CCFAD55FQ61939192-35C55572-81DB-42AA-9587-83C8464F36CBQ61981109-941ECDB7-8B1B-4AA4-BD5D-A55DA8ACF263Q62025451-C3E311F7-2399-4312-8AA3-93995F9C49FFQ62030939-DB4023BD-8ACF-464A-A3C5-057988E007EDQ62031671-F1B804C2-FB84-416A-916C-2B1C9B5E6B7FQ62034483-E2A174BF-8A1D-4272-BC1B-1A349C4AAE52Q62034516-70A197B5-3048-407A-8247-9D717BD76A69Q62034766-21A972A5-97ED-4F82-ABEA-78AF1F5D22C7Q62054263-7D63681D-5FAA-4308-B19B-5D294025B0E4Q63322228-DACB0056-D6AA-49DF-85D3-3E75CF4B11F4Q63336307-C3410631-E8C4-4D61-A5AE-DBB5E301FA72Q63340199-55C1CD7A-DBE6-4442-87B4-5E4BB129373AQ63340343-5C3A9C3A-09B0-477A-91D5-250413B145D0Q63340344-279D45A2-698B-49E0-9769-7DB7E416A4D4Q63394206-7338BE8B-6A7C-46F6-87C5-F90E8DA135F7Q63394303-14B89988-5CCE-4B27-A859-B96522A6E755Q63394673-7118B6A6-A631-4D46-A6C0-E832201B9C80Q63397699-A92C33DD-5621-41DB-889B-8C061DFAA77AQ63399144-4AADEE0A-F1D8-44B8-8288-B57B86E9FF50Q63401696-D261A55D-3C5A-40F5-90EB-D21EF5875186Q63404311-6FD32294-1888-4ADC-BD44-BC1207808D6FQ63405135-D87355E8-02D7-4895-9799-117E48FD2EE9Q63571082-48B75212-8389-4192-992B-141535E53141Q64123586-48C4B699-C2CD-411C-ADB9-451954308E02Q64150432-3EA98F74-4FE5-4891-A840-B9FB632922D7Q64173346-CE8F0AF5-B415-4F0C-8466-39D057D26C4CQ64187770-EE5457E8-7DEB-45CD-8576-093CF1891A3AQ64216726-B76C3C15-B93E-4862-992D-459E245C9629
P6153
description
Krankenhaus in Spanien
@de
griya sakit
@jv
hospital a Espanya
@ca
hospital em Espanha
@pt
hospital en España
@es
hospital en España
@gl
hospital in Spain
@en
hospital n'España
@ast
hôpital en Espagne
@fr
ospedale in Spagna
@it
name
Hospital General Universitario de Alicante
@es
Hospital General Universitario de Alicantet
@en
type
label
Hospital General Universitario de Alicante
@es
Hospital General Universitario de Alicantet
@en
prefLabel
Hospital General Universitario de Alicante
@es
Hospital General Universitario de Alicantet
@en
P214
P950
P131
P1329
+34-965-93-30-00
P17
P18
P213
0000 0000 8875 8879
P214
P2427
grid.411086.a
P2900
+34-965-24-59-71
P3500
P373
Hospital General Universitari d'Alacant
P571
1956-01-01T00:00:00Z
P580
1956-01-01T00:00:00Z
P625
Point (-0.48555555555556 38.363555555556)
P6375
Avenida Pintor Baeza, 12
@es